Endothelial Dysfunction in Obesity-Induced Inflammation: Molecular Mechanisms and Clinical Implications

Obesity is characterized by the excessive deposition of fat that may interfere with the normal metabolic process of the body. It is a chronic condition associated with various metabolic syndromes, whose prevalence is grossly increasing, and affects both children and adults. Accumulation of excessive...

Full description

Bibliographic Details
Main Authors: Ibrahim Kalle Kwaifa, Hasnah Bahari, Yoke Keong Yong, Sabariah Md Noor
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/10/2/291
id doaj-2b1227018cdc47dbae4defc4944e6090
record_format Article
spelling doaj-2b1227018cdc47dbae4defc4944e60902020-11-25T02:20:44ZengMDPI AGBiomolecules2218-273X2020-02-0110229110.3390/biom10020291biom10020291Endothelial Dysfunction in Obesity-Induced Inflammation: Molecular Mechanisms and Clinical ImplicationsIbrahim Kalle Kwaifa0Hasnah Bahari1Yoke Keong Yong2Sabariah Md Noor3Department of Pathology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia (UPM), Selangor 43400, MalaysiaDepartment of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia (UPM), Selangor 43400, MalaysiaDepartment of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia (UPM), Selangor 43400, MalaysiaDepartment of Pathology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia (UPM), Selangor 43400, MalaysiaObesity is characterized by the excessive deposition of fat that may interfere with the normal metabolic process of the body. It is a chronic condition associated with various metabolic syndromes, whose prevalence is grossly increasing, and affects both children and adults. Accumulation of excessive macronutrients on the adipose tissues promotes the secretion and release of inflammatory mediators, including interleukin-6 (IL-6), interleukin 1β, tumor necrotic factor-α (TNF-α), leptin, and stimulation of monocyte chemoattractant protein-1 (MCP-1), which subsequently reduce the production of adiponectin thereby initiating a proinflammatory state. During obesity, adipose tissue synthesizes and releases a large number of hormones and cytokines that alter the metabolic processes, with a profound influence on endothelial dysfunction, a situation associated with the formation of atherosclerotic plaque. Endothelial cells respond to inflammation and stimulation of MCP-1, which is described as the activation of adhesion molecules leading to proliferation and transmigration of leukocytes, which facilitates their increase in atherogenic and thromboembolic potentials. Endothelial dysfunction forms the cornerstone of this discussion, as it has been considered as the initiator in the progression of cardiovascular diseases in obesity. Overexpression of proinflammatory cytokines with subsequent reduction of anti-inflammatory markers in obesity, is considered to be the link between obesity-induced inflammation and endothelial dysfunction. Inhibition of inflammatory mechanisms and management and control of obesity can assist in reducing the risks associated with cardiovascular complications.https://www.mdpi.com/2218-273X/10/2/291obesityadipose tissueinflammationatherosclerosisendothelial dysfunction
collection DOAJ
language English
format Article
sources DOAJ
author Ibrahim Kalle Kwaifa
Hasnah Bahari
Yoke Keong Yong
Sabariah Md Noor
spellingShingle Ibrahim Kalle Kwaifa
Hasnah Bahari
Yoke Keong Yong
Sabariah Md Noor
Endothelial Dysfunction in Obesity-Induced Inflammation: Molecular Mechanisms and Clinical Implications
Biomolecules
obesity
adipose tissue
inflammation
atherosclerosis
endothelial dysfunction
author_facet Ibrahim Kalle Kwaifa
Hasnah Bahari
Yoke Keong Yong
Sabariah Md Noor
author_sort Ibrahim Kalle Kwaifa
title Endothelial Dysfunction in Obesity-Induced Inflammation: Molecular Mechanisms and Clinical Implications
title_short Endothelial Dysfunction in Obesity-Induced Inflammation: Molecular Mechanisms and Clinical Implications
title_full Endothelial Dysfunction in Obesity-Induced Inflammation: Molecular Mechanisms and Clinical Implications
title_fullStr Endothelial Dysfunction in Obesity-Induced Inflammation: Molecular Mechanisms and Clinical Implications
title_full_unstemmed Endothelial Dysfunction in Obesity-Induced Inflammation: Molecular Mechanisms and Clinical Implications
title_sort endothelial dysfunction in obesity-induced inflammation: molecular mechanisms and clinical implications
publisher MDPI AG
series Biomolecules
issn 2218-273X
publishDate 2020-02-01
description Obesity is characterized by the excessive deposition of fat that may interfere with the normal metabolic process of the body. It is a chronic condition associated with various metabolic syndromes, whose prevalence is grossly increasing, and affects both children and adults. Accumulation of excessive macronutrients on the adipose tissues promotes the secretion and release of inflammatory mediators, including interleukin-6 (IL-6), interleukin 1β, tumor necrotic factor-α (TNF-α), leptin, and stimulation of monocyte chemoattractant protein-1 (MCP-1), which subsequently reduce the production of adiponectin thereby initiating a proinflammatory state. During obesity, adipose tissue synthesizes and releases a large number of hormones and cytokines that alter the metabolic processes, with a profound influence on endothelial dysfunction, a situation associated with the formation of atherosclerotic plaque. Endothelial cells respond to inflammation and stimulation of MCP-1, which is described as the activation of adhesion molecules leading to proliferation and transmigration of leukocytes, which facilitates their increase in atherogenic and thromboembolic potentials. Endothelial dysfunction forms the cornerstone of this discussion, as it has been considered as the initiator in the progression of cardiovascular diseases in obesity. Overexpression of proinflammatory cytokines with subsequent reduction of anti-inflammatory markers in obesity, is considered to be the link between obesity-induced inflammation and endothelial dysfunction. Inhibition of inflammatory mechanisms and management and control of obesity can assist in reducing the risks associated with cardiovascular complications.
topic obesity
adipose tissue
inflammation
atherosclerosis
endothelial dysfunction
url https://www.mdpi.com/2218-273X/10/2/291
work_keys_str_mv AT ibrahimkallekwaifa endothelialdysfunctioninobesityinducedinflammationmolecularmechanismsandclinicalimplications
AT hasnahbahari endothelialdysfunctioninobesityinducedinflammationmolecularmechanismsandclinicalimplications
AT yokekeongyong endothelialdysfunctioninobesityinducedinflammationmolecularmechanismsandclinicalimplications
AT sabariahmdnoor endothelialdysfunctioninobesityinducedinflammationmolecularmechanismsandclinicalimplications
_version_ 1724870193783504896